Billionaire Paul Tudor Jones’ Top 5 Stock Picks

4. Immunomedics, Inc. (NASDAQ: IMMU)

Immunomedics, Inc. (NASDAQ: IMMU) is another stock that PTJ added to his top holdings during the third quarter of 2020, by allocating 2% of his fund to this new stock. The position was worth $45.105 million by the end of the quarter, making it the fourth largest holding in his 13F at that time.

On September 13, 2020, Gilead Sciences Inc (NASDAQ: GILD) announced that it will acquire Immunomedics for $21 billion in cash and declared that it entered into strategic collaborations to foray into the lucrative oncology space.

Gilead Sciences Inc. paid $88.00 per share, more than double what IMMU was trading before the announcement ($42.25 per share).